Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

BACKGROUND: ABP 980 has been developed as a biosimilar to Herceptin(®) (trastuzumab). Comprehensive analytical characterization incorporating orthogonal analytical techniques was used to compare ABP 980 to trastuzumab reference products sourced from the United States (US) and the European Union (EU)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutterer, Katariina M., Polozova, Alla, Kuhns, Scott, McBride, Helen J., Cao, Xingxiang, Liu, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533217/
https://www.ncbi.nlm.nih.gov/pubmed/30972630
http://dx.doi.org/10.1007/s40259-019-00350-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533217/
https://www.ncbi.nlm.nih.gov/pubmed/30972630
http://dx.doi.org/10.1007/s40259-019-00350-9

Ejemplares similares